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Pentameric ligand-gated ion channels (pLGICs) mediate fast chemical
neurotransmission of nerve signalling in the central and peripheral nervous
systems. GLIC is a bacterial homologue of eukaryotic pLGIC, the X-ray
structure of which has been determined in three different conformations. GLIC
is thus widely used as a model to study the activation and the allosteric transition
of this family of receptors. The recently solved high-resolution structure of
GLIC (2.4 Å resolution) in the active state revealed two bound acetate
molecules in the extracellular domain (ECD). Here, it is shown that these two
acetates exactly overlap with known sites of pharmacological importance in
pLGICs, and their potential influence on the structure of the open state is
studied in detail. Firstly, experimental evidence is presented for the correct
assignment of these acetate molecules by using the anomalous dispersion signal
of bromoacetate. Secondly, the crystal structure of GLIC in the absence of
acetate was solved and it is shown that acetate binding induces local
conformational changes that occur in strategic sites of the ECD. It is expected
that this acetate-free structure will be useful in future computational studies of
the gating transition in GLIC and other pLGICs.
1. Introduction
Pentameric ligand-gated ion channels (pLGICs) are found
in organisms ranging from prokaryotes to humans. In verte-
brates, these receptors mediate fast neurotransmission in
the central and peripheral nervous systems and include the
nicotinic acetylcholine receptor (nAChR), serotonin receptor
(5HT3), glycine receptor (GlyR) and -aminobutyric acid type
A receptor (GABAA-R). Upon agonist binding in the extra-
cellular domain (ECD) at the interface between subunits,
the pore opens up, allowing ion permeation and therefore
chemoelectric signal transduction. Structural studies of
pLGICs from Gloeobacter violaceus (GLIC) and Erwinia
chrysanthemi (ELIC) as well as the eukaryotic GluCl receptor
from Caenorhabditis elegans and, more recently, the human
GABAA receptor (Miller & Aricescu, 2014) and the mouse
5-HT3 receptor (Hassaine et al., 2014) have provided insights
into the activation and modulation of this family of receptors
(for a review, see Corringer et al., 2012). GLIC presents the
most comprehensive system to date to study the structural
transitions that occur during activation as its structure has
been solved in the active state (Bocquet et al., 2009; Sauguet,
Poitevin et al., 2013), in a locally closed conformation (Prevost
et al., 2012) and recently in the resting state (Sauguet, Shah-
savar, Poitevin et al., 2014). Moreover, GLIC structures in
complex with ethanol and general anaesthetics allowed the
unravelling of several molecular determinants of pLGIC
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Figure 1
(a) Intersubunit site. Acetate-binding sites overlap with known pLGIC modulation/orthosteric sites. Intersubunit site. Upper panel: ELIC with bound
benzodiazepine zopiclone (right), GLIC with bound intersubunit acetate (left) and ELIC and GLIC superimposed with bound zopiclone and acetate,
respectively (centre). Lower panel: ELIC with bound acetylcholine (left), ELIC with bound GABA (right) and ELIC and GLIC superimposed with
bound acetylcholine, GABA and acetate (centre). (b) Intrasubunit site. From left to right: ELIC with glycerol, GlyR 1 model of zinc-mediated
inhibition (Miller et al., 2008), GLIC with bound chloride ion and intrasubunit acetate, ELIC with benzodiazepine flurazepam and GluCl with the pre-5
loop from the neighbouring subunit occupying the intrasubunit site. The same insertion is also seen in GABA-R (4cof ).
allosteric modulation (Nury et al., 2011; Sauguet, Howard et al.
2013). Indeed, Cys-loop receptors (pLGICs) are modulated by
a wide range of molecules, including alcohols, ivermectin,
metal ions, benzodiazepines and general anaesthetics (GAs)
(Miller & Smart, 2010; Corringer et al., 2012). Alcohols and
GAs usually bind at well conserved cavities (either intrasu-
bunit or intersubunit cavities) in the transmembrane domain
(Sauguet, Howard et al., 2013), except for bromoform, which
displays an additional extracellular binding site in ELIC
(Spurny et al., 2013). However, a number of molecules
modulate pLGIC upon binding at the extracellular domain.
For instance, Zn2+ is an allosteric modulator of some members
of the pLGIC family and it modulates the GlyR receptor in a
biphasic fashion through two distinct sites on the ECD
(Bloomenthal et al., 1994; Laube, 2002; Miller et al., 2008; Fig.
4). In addition, benzodiazepines are also known to exert a
biphasic modulation of GABAA receptors through bipartite
binding at both a nanomolar and a micromolar affinity site on
the ECD (Walters et al., 2000). The molecular determinants of
benzodiazepine modulation were further investigated in ELIC
by X-ray crystallography (Spurny et al., 2012). It was found
that they bind with high affinity to a potentiation intrasubunit
site facing the vestibule. They also bind to a second inter-
subunit site that partially overlaps with the orthosteric site and
is a low-affinity inhibitory site.
The recently solved high-resolution structure of GLIC in
the active (open) state revealed the presence of two acetate
molecules (Sauguet, Poitevin et al., 2013). One lies immedi-
ately below the putative orthosteric site. The other acetate
molecule, which had already been observed in the structure of
the ECD alone (Nury et al., 2010), occupies an intrasubunit
pocket located 12 Å away from the first acetate site. Strikingly,
the first acetate site overlaps with the intersubunit inhibition
benzodiazepine site, while the second overlaps with the
intrasubunit potentiation benzodiazepine site (Fig. 1).
Furthermore, in a recent crystallographic study describing the
binding of acetylcholine in the orthosteric site of ELIC (Pan
et al., 2012), extra electron density (interpreted as a glycerol
molecule) was found very close to the intrasubunit acetate-
binding site observed in GLIC (Fig. 1). These findings suggest
that the two acetate molecules bind at well conserved cavities
that correspond to the modulation sites common to many
members of the pLGIC family (Sauguet, Shahsavar &
Delarue, 2014). Moreover, the carboxyl group is present in
most known neurotransmitters (GABA, glycine, glutamate
etc.). Here, we further investigate the possible role of acetate
at the structural level, as we were concerned that acetate
binding might modify the conformation of the GLIC active
state. In particular, we solved the structure of GLIC with a
bromine-substituted derivative of acetate in order to accu-
rately locate the acetate-binding sites in GLIC. We then
analyzed the effect of acetate binding itself by solving the
GLIC structure in a phosphate buffer at the same pH (pH 4).
2. Materials and methods
2.1. Protein production
GLIC fused to maltose-binding protein was expressed in
Escherichia coli C43 cells and purified as described previously
(Sauguet, Poitevin et al., 2013).
2.2. Crystallography
2.2.1. Crystal preparation. All crystals were obtained using
vapour diffusion in hanging drops at 20C.
The concentrated (10 mg ml1) protein was mixed in a 1:1
ratio with reservoir solution typically consisting of 12–14.5%
PEG 4000, 400 mM sodium thiocyanate, 2% dimethyl sulf-
oxide (DMSO), 16% glycerol, 100 mM phosphate buffer pH 4
or sodium acetate pH 4. Crystallization was enhanced by the
micro-seeding technique from a solution of crushed crystals
(grown in the same crystallization condition: 100 mM sodium
acetate pH 4, 400 mM sodium thiocyanate, 16% glycerol, 12%
PEG 4000, 2% DMSO) 1 h after setting up the crystallization
experiment. Crystals appeared overnight with a parallelepiped-
like shape and grew for one week before reaching their final
dimensions.
Bromoacetate-substituted crystals were obtained by adding
4 ml of a solution consisting of 15% PEG 4000, 400 mM
sodium thiocyanate, 2% DMSO, 16% glycerol, 100 mM
bromoacetate pH 4 to the 1 ml crystallization drop containing
the fully grown crystals in sodium acetate buffer pH 4. A short
soak was allowed to occur for 30 s to 3 min, after which the
crystals were directly flash-cooled in liquid nitrogen.
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Table 1
Data-collection and refinement statistics.
Values in parentheses are for the highest resolution shell.
GLIC–phosphate GLIC–bromoacetate
Data collection
Space group C2 C2
Unit-cell parameters
(Å, )
a = 181.9, b = 134.4,
c = 160.0,  = 102.7
a = 181.4, b = 134.0,
c = 158.8,  = 101.0
Resolution (Å) 49.93–2.80 (2.95–2.80) 49.40–3.39 (3.57–3.39)
Rp.i.m. 0.041 (0.846) 0.057 (0.454)
Rmerge 0.060 (1.253) 0.115 (0.910)
CC1/2 0.99 (0.880) 0.99 (0.664)
hI/(I)i 11.2 (1.2) 9.6 (1.8)
Completeness (%) 96.1 (96.7) 99.5 (97.6)
Multiplicity 3.0 (3.0) 5.9 (5.9)
Refinement
Resolution (Å) 20–3.0 20–3.4
No. of reflections 71851 51007
R factor/Rfree (%) 19.9/21.6 20.2/22.5
No. of atoms
Protein 12625 12634
Ligand/ion 205 95
B factors (Å2)
Protein 108.75 119.55
Ligand/ion 100.68 99.5
Ramachandran plot
Favoured (%) 96 98.3
Outliers (%) 0.06 0
MolProbity score† 100th percentile 100th percentile
R.m.s. deviations
Bond lengths (Å) 0.01 0.01
Bond angles () 1.07 1.01
† The 100th percentile is the best among structures of comparable resolution; the 0th is
the worst.
2.2.2. Data collection. All of the crystals were directly
flash-cooled in liquid nitrogen prior to data collection. Data
sets were collected on the PROXIMA1 beamline of the
SOLEIL synchrotron, Gif-sur-Yvette, France and on beamline
ID23-1 of the European Synchrotron Radiation Facility
(ESRF), Grenoble, France. For the bromoacetate-substituted
crystals, data sets were collected at the peak wavelength of
bromine (0.9191 Å). Reflections were integrated using XDS
(Kabsch, 2010) and further processed using programs from the
CCP4 suite (Winn et al., 2011). As expected, crystals of GLIC
grown at pH 4 were isomorphous to the previously described
crystal lattice of the open receptor and belonged to space
group C121 (unit-cell parameters a = 113.5, b = 127.6,
c = 185.8 Å,  =  = 90,  = 101) with one pentamer in the
asymmetric unit (see Table 1).
2.2.3. Phasing and refinement. The phases were directly
calculated by performing rigid-body refinement with
REFMAC5 (Murshudov et al., 2011) using PDB entry 3eam
(Bocquet et al., 2009) as a starting model. The structure was
then subjected to restrained refinement with REFMAC5 using
NCS restraints. The resulting model was improved by manual
building in Coot (Emsley et al., 2010) and was subsequently
refined by BUSTER (Blanc et al., 2004). The final structure
was validated using the MolProbity web server (Chen et al.,
2010). For the bromoacetate-bound GLIC structure, anom-
alous maps were calculated in Coot. The refinement of the
assigned bromoacetate molecules was however complicated
by the fact that the bromoacetate occupancy is apparently
lower than 1.0 owing to incomplete bromoacetate exchange
and to possible radiation damage leading to bromine–carbon
bond cleavage. As a result, we performed one round of
refinement in which the bromine occupancy was allowed to
vary. The mean occupancy of the five Br atoms was refined to a
mean value close to 0.2. A final round of refinement was then
performed after fixing the occupancy of the Br atoms at 0.2. In
the final model, most of the bromoacetate molecules fitted
very well into the 2Fo  Fc density map and the model was
judged to be satisfactory after MolProbity validation.
2.3. Poisson–Boltzmann calculations
Both calculations used in Fig. 4(c) were performed using
AquaSol (Koehl & Delarue, 2010) as described in Sauguet,
Poitevin et al. (2013).
3. Results
3.1. Structural evidence of acetate binding at an intersubunit
site and an intrasubunit site in the GLIC ECD
The high-resolution structure (2.4 Å) of GLIC in the active
state solved at low pH revealed the presence of two bound
acetates per subunit originating from the crystallization buffer
(Sauguet, Poitevin et al., 2013). One acetate molecule binds at
an intersubunit site, the entrance to which lies on the external
side of the receptor below loop C. Acetate is coordinated by
the side chains of residues from the two adjacent monomers:
Arg77 (from loop A) and Glu181 (from loop C) from one
subunit and Arg105 (from loop E) from the neighbouring
subunit (Fig. 2). This pocket is located just below the ortho-
steric site of pLGICs, which is atypical in GLIC owing to the
absence of the ‘aromatic box’ formed by the aromatic residues
from the A, B and C loops involved in agonist binding. The
second acetate molecule binds at an intrasubunit site between
the inner and the outer -sheets, the entrance to which is
research papers
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Figure 2
Detailed view of the two acetate-binding sites in the extracellular domain (ECD) of GLIC. (a) Top view of the receptor. Acetate molecules are shown as
either green or orange spheres. Orange, intrasubunit acetate. Green, intersubunit acetate. Arrows show the entrance path to each site using the same
colour scheme. (b) Molecular determinants of acetate (sticks) binding at the intrasubunit (orange) and the intersubunit (green) sites. Monovalent ions
previously identified are shown as spheres (magenta for Na+, dark red for Cl)
located in the vestibule. The acetate binds through a hydrogen
bond to the side chain of Tyr102 and a salt bridge to the side
chain of Arg 85, which is itself held in place by a salt bridge to
Glu104 (Fig. 2). In order to further confirm acetate binding at
these two sites in the ECD, we solved the GLIC structure in
the presence of bromoacetate, an acetate analogue in which
the methyl group is replaced by a bromomethyl moiety which
produces a specific anomalous signal at the bromine absorp-
tion wavelength. The averaged anomalous map contoured at
3 revealed the presence of three (and only three) strong
anomalous peaks. Two of the peaks correspond to the known
intersubunit and intrasubunit acetate sites and also appear as
positive peaks in the normal Fo Fc density map. This allowed
us to unambiguously assign a bromoacetate molecule per site
in the same orientation as the previously assigned acetates
(Fig. 3). The third strong anomalous peak overlaps with
the previously identified chloride ion, which has also been
successfully replaced by a bromine ion upon crystallization in
the presence of NaBr instead of NaCl (Sauguet, Poitevin et al.,
2013). This suggests that the chloride ion was replaced by a
bromide ion, presumably generated by spontaneous dissocia-
tion of the bromoacatete molecule, during the soaking
experiment (Fig. 2). We conclude that the intersubunit and the
intrasubunit ECD sites are the only acetate sites in GLIC.
3.2. Acetate binding causes a local conformational change in
the extracellular domain of GLIC
In order to assess the effect of acetate binding on the
structure, we solved the structure of GLIC in the absence of
acetate. The acetate buffer was replaced
by phosphate buffer, also at pH 4. The
overall 2.8 Å resolution structure is
highly similar to the acetate-bound
structure, with an r.m.s.d. of 0.4 Å over
all C atoms, but displays significant
differences around the acetate-binding
sites (Fig. 4). This structure is char-
acterized by a marked displacement of
the pre-5 loop, which results in
changes in the orientation of several
charged residues exposed to the lumen
(Figs. 4a and 4b). In particular, Asp86
and Asp88 undergo a reorientation in
the phosphate structure (Fig. 4b). These
Asp residues form a charged ring that
captures cations entering the vestibule.
Indeed, they were shown to bind either
one divalent transition-metal ion (Ni2+)
or two monovalent cations (Rb+) in
GLIC (Fig. 4b; Sauguet, Poitevin et al.,
2013). This rearrangement is likely to
impact the conductivity of the receptor,
as the phosphate structure displays a
lower cation density in the vestibule
compared with the acetate structure
(Fig. 4c). The reorganization observed
in the phosphate structure also involves the acetate-binding
sites, with Arg77 having a pivot role (Figs. 4d, 4e and 4f).
While the intersubunit site is empty in the absence of acetate,
the intrasubunit site is occupied by a chloride ion. Arg77,
which is involved in the intersubunit acetate coordination,
undergoes a major side-chain movement and a change of
rotameric state that can be described as a 102 change of the
dihedral angle around the C—C bond, and now points
towards this chloride ion. In addition, the Asp88 side chain
forms an ion pair with the side chain of Arg77, stabilizing its
new conformation.
4. Discussion
In this study, we characterize two acetate-binding sites in the
GLIC ECD and describe its acetate-free open form by X-ray
crystallography. This latter structure shows nontrivial confor-
mational rearrangements in the ECD that should be consid-
ered. On the one hand, acetate binding occurs at well
conserved pockets near the pLGIC orthosteric site that
harbour allosteric modulators in some other pLGICs (Spurny
et al., 2012; Miller et al., 2008). Thus, these sites are also likely
to represent modulation sites in GLIC. This hypothesis is
further reinforced by a recent study that revealed a new class
of allosteric modulators targeting the extracellular domain of
GLIC (Prevost et al., 2013). These molecules include cinnamic
acid and caffeic acid derivatives that inhibit GLIC currents
with micromolar affinity. Interestingly, their carboxylate group
has been shown to be compulsory for the inhibitory effect, and
their binding site was mapped by molecular docking and
research papers
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Figure 3
Evidence of two unique acetate-binding sites in the GLIC ECD as confirmed by the bromoacetate-
bound structure (PDB entry 4qh1). (a) Intrasubunit site. (b) Intersubunit site. Orange map:
averaged anomalous density map of bromoacetate contoured at 3. Blue map, 2Fo Fc density map
contoured at 1. Upper panel, acetate; lower panel, bromoacetate.
mutagenesis experiments to be in the vicinity of the pLGIC
orthosteric site. In particular, for the Arg77Ala mutant the
inhibition concentration shifts to higher concentrations by
more than tenfold. This residue, which is involved in the
coordination of the intersubunit acetate in GLIC (see Fig. 3),
undergoes a significant side-chain rearrangement in our
acetate-free structure. This may suggest that it is indeed
important for GLIC modulation by acetate derivatives. In any
case, further structural and functional studies will be needed in
order to assess whether the described acetate-binding sites
could indeed represent GLIC modulation sites.
The acetate-induced conformational rearrangement involves
charged residues on the ECD. These rearrangements are
particularly important to consider for GLIC which is activated
by protons and no ‘sizable’ agonist targeting GLIC has been
identified to date (Bocquet et al., 2007). At the molecular
level, this may be owing to the absence of the characteristic
‘aromatic box’ located at the ECD at the interspace between
subunits and which is involved in ligand binding in canonical
pLGIC orthosteric sites (Nys et al., 2013). In GLIC, this
‘aromatic box’ is replaced by a patch of charged residues,
among which Arg133 partially obstructs the putative ortho-
steric pocket. To date, the proton-elicited activation mode of
GLIC has not been completely elucidated. It is however safe
to assume that at least one of the proton-binding sites is
located in the ECD, as a chimera of GLIC ECD fused to the
TMD of the human 1 glycine receptor (1GlyR) has also
been shown to be activated by protons (Duret et al., 2011). As
a result, any attempt to study the proton-elicited activation
should take into account the conformation described here for
the charged residues in the ECD.
The new acetate-free structure described here should be
considered to be the unbiased active (open) structure of GLIC
devoid of the conformational rearrangement owing to acetate
binding. Although this structure displays only small confor-
mational changes compared with the acetate-bound structure,
the rearrangements observed upon acetate binding involve a
key region where both GluCl and GABA-R place an insertion
(Fig. 1). Actually GluCl has its aspartate D104 side chain
exactly on the intrasubunit acetate binding site of GLIC. Thus,
this rearrangement should be taken into account when
performing calculations that require accurate structural
information. For instance, molecular-dynamics simulations
are usually performed based on GLIC structures in order to
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Figure 4
Comparison of the GLIC–acetate structure (PDB entry 4hfi, pink; Sauguet, Poitevin et al., 2013) with the GLIC–phosphate structure (PDB entry 4qh5,
deep blue; this work) both at pH 4. (a, b, c) Asp86–Asp88 movement. (a) Superimposition of the pentamers. Black arrows highlight the movements of the
pre-5 loops. (b) Change of conformers of the pre-5 loop residues Asp86 and Asp88. Divalent or monovalent ions observed in different GLIC
structures are also shown as coloured spheres [green sphere, Ni2+ ion (PDB entry 4npp; Sauguet, Shahsavar, Poitevin et al., 2014); golden sphere, Cd2+
ion (PDB entry 2xq7; Hilf et al., 2010); violet spheres, Cs+ ions (PDB entry 4ila; Sauguet, Poitevin et al., 2013)]. (c) Cation density map in the vestibule in
the two structures calculated by AquaSol (using an implementation available online at http://lorentz.dynstr.pasteur.fr; Koehl & Delarue, 2010). (d, e, f )
The pivot movement of the Arg77 side chain in the phosphate structure. (d) The Arg77 side chain points away from the empty intersubunit binding site.
(e) The Arg77 side chain points to a chloride ion occupying the intrasubunit binding site; the black arrow highlights the 5 Å translation of the Arg77 side
chain between the acetate and the phosphate structures. ( f ) Creation of an Arg77/Asp88 ion pair in the phosphate structure. The tip of the Arg77 side
chain switches from the acetate intersubunit site to the acetate intrasubunit site and changes the conformation of Asp88.
characterize the ion conduction, the gating mechanism and the
allosteric transitions of Cys-loop family receptors (Calimet et
al., 2013; Velisetty et al., 2014; Zhu & Hummer, 2012). Such
simulations should now be performed using the GLIC acetate-
free structure described in this study as the real open form of
the receptor.
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